Brittany Gisi1, Andrew D Althouse2, Abigail S Mathier2, Alexandra Pusateri1, Bruce L Rollman3, Anna LaRosa2, Jared W Magnani4. 1. School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 2. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 3. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Center for Behavioral Health and Smart Technology, Pittsburgh, PA, USA. 4. Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Division of Cardiology, UPMC Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: magnanij@pitt.edu.
Abstract
INTRODUCTION: Patient-reported outcomes are routinely assessed in atrial fibrillation (AF) to evaluate efficacy of treatment and as clinical trial outcomes. The relation of depression to such measures has had limited study in AF. METHODS: In a cohort receiving treatment for AF, we assessed depression with the Patient Health Questionniare-9 (PHQ; 0-4, normal range; 5-9, mild depression; ≥10 moderate depression). We related depression to disease-specific quality of life with the AF Effect on QualiTy of life (AFEQT, range 0-100) and the Global Perceived Stress Scale (GPPS, range 0-24) in multivariable-adjusted models. RESULTS: In 260 individuals (age 71.7 ± 10.1, 44.6% women) with AF, 51 (26.1%) had PHQ scores ≥5 and 17 (6.5%) ≥10. AFEQT scores decreased progressively with depression severity (normal range PHQ, 81.4 ± 14.1; mild depression, 65.8 ± 17.1; moderate depression, 50.6 ± 19.3). Individuals without depression had lower GPPS scores (3.0 ± 2.6) than those with mild (4.9 ± 2.5) or moderate (8.9 ± 4.0) depression. In multivariable-adjusted models mild depression was associated with a 12.1-point (95% confidence interval [CI], -17.2 to -6.9) decrease in AFEQT and 1.9-point (95% CI, 1.1 to 2.7) increase in GPSS, while moderate depression a 27.7-point (95% CI, -35.5 to -19.8) decrease in AFEQT and 5.5-point (95% CI, 4.2 to 6.8) increase in GPSS, relative to normal range PHQ. Regression analyses confirmed significant correlations between depression and AFEQT and GPPS scores in multivariable-adjusted models. CONCLUSIONS: We determined that depression is associated with a step-wise, progressively adverse change in patient-centered outcomes in individuals with AF. Our findings suggest the importance of assessing depression in the evaluation of AF. Subject term list: health services, atrial fibrillation, risk factors.
INTRODUCTION: Patient-reported outcomes are routinely assessed in atrial fibrillation (AF) to evaluate efficacy of treatment and as clinical trial outcomes. The relation of depression to such measures has had limited study in AF. METHODS: In a cohort receiving treatment for AF, we assessed depression with the Patient Health Questionniare-9 (PHQ; 0-4, normal range; 5-9, mild depression; ≥10 moderate depression). We related depression to disease-specific quality of life with the AF Effect on QualiTy of life (AFEQT, range 0-100) and the Global Perceived Stress Scale (GPPS, range 0-24) in multivariable-adjusted models. RESULTS: In 260 individuals (age 71.7 ± 10.1, 44.6% women) with AF, 51 (26.1%) had PHQ scores ≥5 and 17 (6.5%) ≥10. AFEQT scores decreased progressively with depression severity (normal range PHQ, 81.4 ± 14.1; mild depression, 65.8 ± 17.1; moderate depression, 50.6 ± 19.3). Individuals without depression had lower GPPS scores (3.0 ± 2.6) than those with mild (4.9 ± 2.5) or moderate (8.9 ± 4.0) depression. In multivariable-adjusted models mild depression was associated with a 12.1-point (95% confidence interval [CI], -17.2 to -6.9) decrease in AFEQT and 1.9-point (95% CI, 1.1 to 2.7) increase in GPSS, while moderate depression a 27.7-point (95% CI, -35.5 to -19.8) decrease in AFEQT and 5.5-point (95% CI, 4.2 to 6.8) increase in GPSS, relative to normal range PHQ. Regression analyses confirmed significant correlations between depression and AFEQT and GPPS scores in multivariable-adjusted models. CONCLUSIONS: We determined that depression is associated with a step-wise, progressively adverse change in patient-centered outcomes in individuals with AF. Our findings suggest the importance of assessing depression in the evaluation of AF. Subject term list: health services, atrial fibrillation, risk factors.
Authors: Per Wändell; Axel C Carlsson; Danijela Gasevic; Lars Wahlström; Jan Sundquist; Kristina Sundquist Journal: Ann Med Date: 2016-01-13 Impact factor: 4.709
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: Anil K Gehi; Samuel Sears; Neeta Goli; T Jennifer Walker; Eugene Chung; Jennifer Schwartz; Kathryn A Wood; Kimberly Guise; J Paul Mounsey Journal: J Cardiovasc Electrophysiol Date: 2012-03-19
Authors: Malavika A Subramanyam; Ana V Diez-Roux; Demarc A Hickson; Daniel F Sarpong; Mario Sims; Herman A Taylor; David R Williams; Sharon B Wyatt Journal: Soc Sci Med Date: 2012-02-14 Impact factor: 4.634
Authors: Michelle A Albert; Eva M Durazo; Natalie Slopen; Alan M Zaslavsky; Julie E Buring; Ted Silva; Daniel Chasman; David R Williams Journal: Am Heart J Date: 2017-06-28 Impact factor: 4.749
Authors: Daniel B Mark; Kevin J Anstrom; Shubin Sheng; Jonathan P Piccini; Khaula N Baloch; Kristi H Monahan; Melanie R Daniels; Tristram D Bahnson; Jeanne E Poole; Yves Rosenberg; Kerry L Lee; Douglas L Packer Journal: JAMA Date: 2019-04-02 Impact factor: 56.272
Authors: Helen T Paradise; Dan R Berlowitz; Al Ozonoff; Donald R Miller; Elaine M Hylek; Arlene S Ash; Guneet K Jasuja; Shibei Zhao; Joel I Reisman; Adam J Rose Journal: J Gen Intern Med Date: 2014-02-19 Impact factor: 5.128
Authors: Thomas Meyer; Bea Herbeck Belnap; Christoph Herrmann-Lingen; Fanyin He; Sati Mazumdar; Bruce L Rollman Journal: J Psychosom Res Date: 2013-11-05 Impact factor: 3.006
Authors: Robert Neal Axon; Mulugeta Gebregziabher; Kelly J Hunt; Cheryl P Lynch; Elizabeth Payne; Rebekah J Walker; Leonard E Egede Journal: Medicine (Baltimore) Date: 2016-06 Impact factor: 1.889
Authors: Raisa L Silva; Emily N Guhl; Andrew D Althouse; Brandon Herbert; Michael Sharbaugh; Utibe R Essien; Leslie R M Hausmann; Jared W Magnani Journal: Am J Prev Cardiol Date: 2021-09-03